These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21765019)

  • 1. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study.
    Pengo V; Ruffatti A; Legnani C; Testa S; Fierro T; Marongiu F; De Micheli V; Gresele P; Tonello M; Ghirarduzzi A; Bison E; Denas G; Banzato A; Padayattil Jose S; Iliceto S
    Blood; 2011 Oct; 118(17):4714-8. PubMed ID: 21765019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
    Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
    Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity.
    Yelnik CM; Urbanski G; Drumez E; Sobanski V; Maillard H; Lanteri A; Morell-Dubois S; Caron C; Dubucquoi S; Launay D; Duhamel A; Hachulla E; Hatron PY; Lambert M
    Lupus; 2017 Feb; 26(2):163-169. PubMed ID: 27432808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody profiles for the diagnosis of antiphospholipid syndrome.
    Pengo V; Biasiolo A; Pegoraro C; Cucchini U; Noventa F; Iliceto S
    Thromb Haemost; 2005 Jun; 93(6):1147-52. PubMed ID: 15968401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis.
    Abdel-Wahab N; Talathi S; Lopez-Olivo MA; Suarez-Almazor ME
    Lupus; 2018 Apr; 27(4):572-583. PubMed ID: 28945149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies.
    Kim KJ; Baek IW; Yoon CH; Kim WU; Cho CS
    Br J Haematol; 2013 Jun; 161(5):706-714. PubMed ID: 23530551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-domain 1 of beta2-glycoprotein I aids risk stratification in lupus anticoagulant-positive patients.
    Guo H; Zhang Y; Li A; Wang C; Yang S; Zhang Y; Zhang J; Qiao R
    Clin Exp Med; 2019 Aug; 19(3):339-345. PubMed ID: 31093818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Length of exposure to antiphospholipid antibodies, rather than age, is a risk factor for thrombosis: a retrospective single-centre observational study.
    Les I; Parraza N; Anaut P; Eguiluz S; Sánchez C; Preciado ME; Loza JÁ; Andía A
    Rheumatol Int; 2018 Feb; 38(2):229-238. PubMed ID: 29124399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel enzyme immunoassay system for simultaneous detection of six subclasses of antiphospholipid antibodies for differential diagnosis of antiphospholipid syndrome.
    Nojima J; Motoki Y; Hara K; Sakata T; Ichihara K
    Blood Coagul Fibrinolysis; 2017 Jun; 28(4):316-322. PubMed ID: 27676644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies.
    Lazzaroni MG; Fredi M; Andreoli L; Chighizola CB; Del Ross T; Gerosa M; Kuzenko A; Raimondo MG; Lojacono A; Ramazzotto F; Zatti S; Trespidi L; Meroni PL; Pengo V; Ruffatti A; Tincani A
    Front Immunol; 2019; 10():1948. PubMed ID: 31475009
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.
    Fredi M; Andreoli L; Aggogeri E; Bettiga E; Lazzaroni MG; Le Guern V; Lojacono A; Morel N; Piette JC; Zatti S; Costedoat-Chalumeau N; Tincani A
    Front Immunol; 2018; 9():864. PubMed ID: 29867924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant.
    Pengo V; Testa S; Martinelli I; Ghirarduzzi A; Legnani C; Gresele P; Passamonti SM; Bison E; Denas G; Jose SP; Banzato A; Ruffatti A
    Thromb Res; 2015 Jan; 135(1):46-9. PubMed ID: 25456002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
    Forastiero R
    Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical manifestations and thrombotic risk factors in primary antiphospholipid syndrome].
    Zhao JL; Sun YD; Zhang Y; Xu D; Wang Q; Li MT; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):386-91. PubMed ID: 27143190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study.
    Tonello M; Mattia E; Del Ross T; Favaro M; Calligaro A; Hoxha A; Bison E; Pengo V; Ruffatti A
    Clin Chim Acta; 2018 Oct; 485():74-78. PubMed ID: 29953850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.
    Girón-González JA; García del Río E; Rodríguez C; Rodríguez-Martorell J; Serrano A
    J Rheumatol; 2004 Aug; 31(8):1560-7. PubMed ID: 15290736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria.
    Litvinova E; Darnige L; Kirilovsky A; Burnel Y; de Luna G; Dragon-Durey MA
    Front Immunol; 2018; 9():2971. PubMed ID: 30619328
    [No Abstract]   [Full Text] [Related]  

  • 20. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
    Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
    Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.